You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 37 No. 6, June 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hydrolytic Enzyme Activities of the Nervous System

Robert B. Ramsey, PhD; Kenneth R. Smith, Jr, MD; David C. Crafts, MD; Hyung D. Chung, MD; Michael Fredericks, MD

Arch Neurol. 1980;37(6):356-359.


Abstract

• The activities of five hydrolytic enzymes (acid and alkaline phosphatase, hexosaminidase [N-acetyl-β-D-glucosaminidase], β-galactosidase, and β-glucuronidase) were measured in reconstituted homogenates of lyophilized human brain tissue and primary and metastatic tumors. The linearity of reaction, with respect to incubation time, and optimal pH of each enzyme and in tumor tissues were comparable to those in normal brain tissue. Total enzyme activities of hexosaminidase, β-glucuronidase, and β-galactosidase were significantly higher in tumors than in normal cerebral white matter. The ratio of hexosaminidase activity to β-glucuronidase activity was significantly lower for metastatic than for primary tumors or normal white matter. When histological observations do not clearly establish if a brain tumor is primary or metastatic, this ratio may help. Alteration of hydrolytic enzyme activities as demonstrated here may be indicative of "key enzymes" that are essential for maintaining the metabolic advantages of tumors.



Author Affiliations

From the Department of Neurology (Drs Ramsey and Fredericks) and the Section of Neurosurgery (Drs Smith and Crafts), St Louis University School of Medicine, and the Department of Pathology, John Cochran Veterans Administration Hospital (Dr Chung), St Louis.


Footnotes

Accepted for publication July 1, 1979.

Adapted from a preliminary report read before the Eighth International Congress of the International Society of Neuropathology, Washington, DC, Sept 25, 1978.

Reprint requests to Department of Neurology, St Louis University School of Medicine, St Louis, MO 63104 (Dr Ramsey).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.